MX1 is considered as an ideal and specific marker for the activity of the IFNα signalling pathway.13 Consistently, we observed an increase MX1 (Fig. 1h) and STAT1 expression in HNSCC patients in Oncomine (Supplementary Fig. S4E, F). The gene discussed is STAT1; the disease is head and neck squamous cell carcinoma.